Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

News > All

Total search results: 5466 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 46 47 48 ... 53 54 55  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Gilead Sciences, Inc.. (10/3/17). "Press Release: Gilead Sciences Completes Acquisition of Kite Pharma, Inc.". Foster City, CA. 2017-10-03
Cullinan Oncology, LLC. (10/3/17). "Press Release: Cullinan Oncology Secures $150 Million Series A Financing To Build Innovative Development Company". Cambridge, MA. 2017-10-03
Bruker Corporation. (10/2/17). "Press Release: Bruker Launches the Alpha II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control". Billerica, MA. 2017-10-02
CRISPR Therapeutics AG. (10/2/17). "Press Release: CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer". Zug & Cambridge, MA. 2017-10-02
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA. 2017-10-02
Qiagen N.V.. (10/2/17). "Press Release: Qiagen Achieves ISO Certification for State-of-the-Art Quality in Forensics". Hilden & Germantown, MD. 2017-10-02
Roche. (9/29/17). "Press Release: FDA Grants Priority Review for Roche’s Perjeta (pertuzumab) for Adjuvant Treatment of HER2-positive Early Breast Cancer". Basel. 2017-09-29
Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. 2017-09-29
Novartis AG. (9/28/17). "Press Release: Novartis and UC Berkeley Collaborate to Tackle »Undruggable« Disease Targets". Basel. 2017-09-28
Evotec AG. (9/28/17). "Press Release: Evotec Invests in Exscientia to Advance AI-driven Drug Discovery". Hamburg & Dundee. 2017-09-28
Immatics Biotechnologies GmbH. (9/28/17). "Press Release: Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine Approach in Patients with Advanced Solid Cancers". Houston, TX & Tübingen. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
Roche. (9/28/17). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in Switzerland for Primary Progressive and Relapsing Forms of Multiple Sclerosis". Basel. 2017-09-28
ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. 2017-09-28
Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel. 2017-09-28
Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. 2017-09-28
Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. 2017-09-27
Bruker Corporation. (9/26/17). "Press Release: Bruker Announces Acquisition of Merlin to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper Microbial Identification Platform". Bremen. 2017-09-26
Juno Therapeutics, Inc.. (9/26/17). "Press Release: Juno Therapeutics Closes Follow-on Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Seattle, WA. 2017-09-26
Roivant Sciences GmbH. (9/26/17). "Press Release: Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer’s Disease". Basel. 2017-09-26
AvroBio, Inc.. (9/26/17). "Press Release: AvroBio, Inc. Appoints Katina Dorton as Chief Financial Officer". Cambridge, MA. 2017-09-26
Novartis AG. (9/22/17). "Press Release: Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-income Countries". Basel. 2017-09-22
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Prices $250 Million Follow-on Offering". Seattle, WA. 2017-09-21
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Opens New Headquarters and Research Center". Seattle, WA. 2017-09-21
Humabs BioMed S.A.. (9/21/17). "Press Release: Data on Novel Bi-specific Antibody to Treat Zika Virus Infection Published in »Cell«". 2017-09-21
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Roivant Sciences GmbH. (9/20/17). "Press Release: Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence". San Francisco, CA & Basel. 2017-09-20
Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel. 2017-09-20
Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. 2017-09-19
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2017-09-18
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King 2017-09-18
Roivant Sciences GmbH. (9/18/17). "Press Release: Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer". Basel. 2017-09-18
Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. 2017-09-18
ThromboGenics N.V.. (9/18/17). "Press Release: ThromboGenics Regains Global Rights to Jetrea (ocriplasmin)". Leuven. 2017-09-18
High-Tech Gründerfonds Management GmbH. (9/18/17). "Press Release: Evonik Is Investing in Numaferm, a Specialist in the Biotechnological Production of Peptides". 2017-09-18
Ncardia. (9/18/17). "Press Release: Ncardia Established Following Pluriomics Axiogenesis Merger". Gosselies, Cologne, Leiden & Philadelphia, PA. 2017-09-18
Tolremo Therapeutics AG. (9/18/17). "Press Release: Tolremo Therapeutics AG – Preventing Drug Resistance in Cancer Therapy". Zürich. 2017-09-18
Bayer AG. (9/15/17). "Press Release: Bayer Receives Positive CHMP Opinion for Rivaroxaban 10 mg Once Daily for the Extended Prevention of Venous Thromboembolism [Not intended for U.S. and UK Media]". Berlin. 2017-09-15
Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków. 2017-09-15
Santhera Pharmaceuticals Holding AG. (9/15/17). "Press Release: Santhera Receives Negative Opinion from the CHMP for Its Marketing Authorization Application for Raxone in DMD and Intends to Appeal this Opinion". Liestal. 2017-09-15
Boehringer Ingelheim. (9/15/17). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Adalimumab Biosimilar Cyltezo". Ingelheim. 2017-09-15
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
Adecco Group AG. (9/14/17). "Press Release: The Adecco Group Announces Acquisition of BioBridges". Zurich. 2017-09-14
Bayer AG. (9/14/17). "Press Release: Bayer and Ginkgo Bioworks Join Forces for Sustainable Agriculture, Forming New Company with USD 100 million Series A". Leverkusen & Boston, MA. 2017-09-14
Evotec AG. (9/14/17). "Press Release: Evotec and MaRS Innovation Establish Academic Bridge »LAB150« in Toronto". Hamburg. 2017-09-14
Leukocare AG. (9/14/17). "Press Release: Leukocare Continues to Expand and Invests in Research and Development". Munich. 2017-09-14
Lipotype GmbH. (9/13/17). "Press Release: Lipid Analysis for Early Stages of Drug Discovery – Customer Reference Flagship VentureLabs". 2017-09-13
Sophia Genetics S.A.. (9/13/17). "Press Release: Sophia Genetics Raises $30 Million in Series D Funding to Accelerate Its Mission of Democratizing Data-driven Medicine Worldwide". St. Sulpice. 2017-09-13
Genenta Science S.r.l.. (9/13/17). "Press Release: Genenta Raised Other $8,4 Million (€7 Million) in the Second Round of Financing - Total Raised in Two Rounds, $20,4 Million (€17 Million) -". Milano. 2017-09-13
Roivant Sciences GmbH. (9/13/17). "Press Release: Roivant Strengthens Executive Team with Key Hires and Promotions. Former GC of Pfizer Allen Waxman Joins Roivant". Basel. 2017-09-13
Affimed N.V.. (9/13/17). "Press Release: Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer". Heidelberg. 2017-09-13
BC Platforms AG. (9/13/17). "Press Release: BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource". 2017-09-13
Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. 2017-09-13
GreenLight Biosciences, Inc.. (9/13/17). "Press Release: GreenLight Biosciences Announces Series D Financing, Unveils RNA Strategy". Medford, MA. 2017-09-13
Bayer AG. (9/12/17). "Press Release: Wolfgang Nickl to Be New Chief Financial Officer at Bayer AG". Leverkusen. 2017-09-12
Berkeley Lights, Inc.. (9/12/17). "Press Release: Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery". Emeryville, CA. 2017-09-12
DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. 2017-09-12
Ayoxxa Biosystems GmbH. (9/11/17). "Press Release: Ayoxxa Introduces Lunaris, Its Advanced Fully Integrated Low-volume Beads-on-a-Chip Multiplex Protein Analysis System". Cologne. 2017-09-11
Bayer AG. (9/11/17). "Press Release: Bayer and Vanderbilt University Medical Center Collaborate to Develop Therapies against Kidney Diseases [Not intended for U.S. and UK Media]". Berlin. 2017-09-11
NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin. 2017-09-11
Evotec AG. (9/8/17). "Press Release: European Investment Bank Supports Evotec’s Innovate Strategy with EUR 75 M Loan". Hamburg & Brussels. 2017-09-08
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
Leap Therapeutics, Inc.. (9/8/17). "Press Release: Leap Therapeutics Announces Collaboration with EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers". Cambridge, MA. 2017-09-08
Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. 2017-09-08
Epigenomics AG. (9/8/17). "Press Release: Epigenomics AG Issues Convertible Bonds". Berlin & Germantown, MD. 2017-09-08
Evotec AG. (9/7/17). "Press Release: Evotec and Abivax Enter into Strategic Collaboration to Develop Novel Antiviral Agents". Hamburg & Paris. 2017-09-07
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Wins New Long-term Oriented Investor by Way of a Capital Increase. DAH Beteiligungs GmbH Is New, Long-term Oriented Investor of BRAIN AG Supporting Its Growth Strategy". Zwingenberg. 2017-09-07
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Resolves Upon Capital Increase – New Long-term Investor Subscribes All New Shares [Ad-hoc News]". Zwingenberg. 2017-09-07
Bayer AG. (9/7/17). "Press Release: Bayer Submits Marketing Authorization Application for BAY94-9027 for the Treatment of Hemophilia A in the EU [Not intended for U.S. and UK Media]". Berlin. 2017-09-07
Boehringer Ingelheim. (9/7/17). "Press Release: Boehringer Ingelheim and Gubra Collaborate to Develop Next Generation Obesity Treatments". Ingelheim & Hørsholm. 2017-09-07
Markes International Ltd.. (9/7/17). "Press Release: Markes International Opens New Chinese Subsidiary in Shanghai". 2017-09-07
InflaRx GmbH. (9/7/17). "Press Release: InflaRx Reports Topline Phase IIa Clinical Results of IFX-1 for the Treatment of Hidradenitis Suppurativa". Jena. 2017-09-07
MorphoMed GmbH. (9/7/17). "Press Release: MorphoMed – New Start-up Focusing on Next-generation Tissue Engineering in Vienna". 2017-09-07
Labster ApS. (9/6/17). "Press Release: Education Tech Startup Labster Raises $10m in Series A Funding to Bring Virtual Lab Simulations to Students around the World". Copenhagen. 2017-09-06
Merck & Co., Inc.. (9/6/17). "Press Release: Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology". Kenilworth, NJ & Munich. 2017-09-06
Bruker Corporation. (9/6/17). "Press Release: Bruker Announces the New D8 Discover Plus XRD System". Chiba. 2017-09-06
Metabolomic Discoveries GmbH. (9/5/17). "Press Release: Metabolon Acquires Metabolomic Discoveries GmbH". Research Triangle Park, NC. 2017-09-05
Immunic AG. (9/5/17). "Press Release: Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million". Planegg-Martinsried. 2017-09-05
Merck KGaA. (9/5/17). "Press Release: Merck Prepares Strategic Options for the Consumer Health Business. Important Step in Executing Science and Technology Focused Strategy". Darmstadt. 2017-09-05
Amal Therapeutics S.A.. (9/5/17). "Press Release: Amal Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round". Geneva. 2017-09-05
Phenomenex, Inc.. (9/5/17). "Press Release: Phenomenex Announces Direct Sales and Support in Switzerland". Torrance, CA. 2017-09-05
Global Antibiotic Research and Development Partnership (GARDP). (9/4/17). "Press Release: More than EUR 56 Million Raised to Fund Initiative to Fight Antibiotic Resistance". Berlin. 2017-09-04
Allcyte GmbH. (9/4/17). "Press Release: Allcyte Collaborates with Boehringer Ingelheim to Advance Preclinical Oncology Drug Discovery by Using Novel Drug Response Profiling Technology". Vienna. 2017-09-04
Merck KGaA. (9/1/17). "Press Release: Successful Closing of Biosimilars Transaction". Darmstadt. 2017-09-01
Merck KGaA. (9/1/17). "Press Release: Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci". Darmstadt. 2017-09-01
Grünenthal GmbH. (9/1/17). "Press Release: Mark Fladrich Takes Office as the New CCO of the Grünenthal Group". Aachen. 2017-09-01
Amcure GmbH. (8/31/17). "Press Release: Amcure Receives Additional €1.75M BMBF Research Grant". Eggenstein-Leopoldshafen. 2017-08-31
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. 2017-08-31
Eurofins Scientific. (8/30/17). "Press Release: Eurofins Reports Solid H1 2017 Results with 15.6% Revenue Growth on the Back of an Organic growth of about 6% and over 35 Acquisitions". 2017-08-30
Evolva Holding S.A.. (8/30/17). "Press Release: Evolva Announces Major Restructuring for Next Phase of Its Development". 2017-08-30
Merck KGaA. (8/30/17). "Press Release: Merck Opens Its First Customer Food Safety Studio". Darmstadt. 2017-08-30
Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg. 2017-08-30
Novartis AG. (8/30/17). "Press Release: Novartis Receives First Ever FDA Approval for a CAR-T Cell Therapy, Kymriah (CTL019), for Children and Young Adults with B-cell ALL that is Refractory or Has Relapsed at Least Twice". Basel. 2017-08-30
Epigenomics AG. (8/30/17). "Press Release: Epigenomics Commences Post Approval Study on Epi proColon". Berlin & Germantown, MD. 2017-08-30
Forge Therapeutics, Inc.. (8/29/17). "Press Release: Forge Therapeutics and Evotec to Present Preclinical Data on Novel Antibiotic Program at 2017 ASM/ESCMID Conference". San Diego, CA. 2017-08-29
Merck KGaA. (8/29/17). "Press Release: Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy". Darmstadt. 2017-08-29
next pagenext page 1 2 3 ... 46 47 48 ... 53 54 55  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Biotech Showcase 2024 San Francisco 650x300px

» top